KIA BROWN: Open Payments
NPI 1689273385 · REDONDO BEACH, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$458 in 20 payments from 13 companies in 2025. Trend: 2023 $723 · 2024 $512 · 2025 $458
Food & beverage: $458
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $63 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| PFIZER INC. | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Sage Therapeutics, LLC | 2 | $46 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $39 |
| Cranial Technologies, Inc | 2 | $36 |
| Novo Nordisk Inc | 1 | $27 |
| GENZYME CORPORATION | 1 | $26 |
| Lilly USA, LLC | 1 | $23 |
Products named: QULIPTA, PREVNAR 20, NUCALA, ZURZUVAE, NEFFY, Doc Band, Wegovy, AYVAKIT.
Industry payments across CA — which companies pay providers there.
